Alumis
Raina Thomas is an experienced administrative professional with a robust background in executive assistance and administrative support. Currently serving as an Executive Assistant at Alumis since July 2022, Raina previously held the position of Senior Administrative Assistant II at Bristol Myers Squibb following its acquisition in November 2019. Raina's career includes roles at Celgene as a Senior Administrative Assistant, and multiple positions at Genentech, beginning as a Sr. Administrative Associate and progressing through various associate roles from 2012 to 2018. Earlier experience includes an administrative role at Gap Inc. and an extensive tenure at Morrow-Meadows Corp. Raina holds an Associate of Arts and Sciences degree in Biology from Skyline College, earned between 1994 and 1999.
This person is not in any teams
Alumis
2 followers
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction. Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.